BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23545363)

  • 1. Novel strategies towards the use of anti-angiogenic agents in breast cancer.
    Bakker JL; Meijers-Heijboer H; Verheul H
    Eur J Pharmacol; 2013 Oct; 717(1-3):36-9. PubMed ID: 23545363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab for advanced breast cancer.
    Traina TA; Rugo HS; Dickler M
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):303-19. PubMed ID: 17512451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple-negative breast cancer: role of antiangiogenic agents.
    Greenberg S; Rugo HS
    Cancer J; 2010; 16(1):33-8. PubMed ID: 20164688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis targeting in breast cancer].
    Fumoleau P; Coudert B; Mayer F; Isambert N; Favier L; Ferrant E
    Bull Cancer; 2007; 94(7 Suppl):F199-206. PubMed ID: 17964997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic treatment in breast cancer: Facts, successes, failures and future perspectives.
    Aalders KC; Tryfonidis K; Senkus E; Cardoso F
    Cancer Treat Rev; 2017 Feb; 53():98-110. PubMed ID: 28088074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: clinical experience with anti-angiogenic agents, focusing on bevacizumab.
    Marty M; Pivot X
    Eur J Cancer; 2008 May; 44(7):912-20. PubMed ID: 18396037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting angiogenesis in head and neck cancer.
    Seiwert TY; Cohen EE
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis as a target for breast cancer therapy.
    Rayson D; Vantyghem SA; Chambers AF
    J Mammary Gland Biol Neoplasia; 1999 Oct; 4(4):415-23. PubMed ID: 10705924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tumour angiogenesis.
    Fox SB; Generali DG; Harris AL
    Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiogenesis and breast cancer].
    Bachelot T; Ray-Coquard I; Cassier P; Blay JY
    Bull Cancer; 2007 Jul; 94 Spec No():S203-10. PubMed ID: 17846006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
    Miller KD
    Breast Cancer Res; 2004; 6(3):128-32. PubMed ID: 15084233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab for the first-line treatment of human epidermal growth factor receptor 2-negative advanced breast cancer.
    Damasceno M
    Curr Opin Oncol; 2011 Apr; 23 Suppl():S3-9. PubMed ID: 21490481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapies in breast cancer.
    Sarmiento R; D'Andrea MR; Cacciamani F; Salerno F; Gasparini G
    Curr Opin Investig Drugs; 2009 Dec; 10(12):1334-45. PubMed ID: 19943205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?
    Bozza C; Fontanella C; Buoro V; Mansutti M; Aprile G
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):251-65. PubMed ID: 25597501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenesis in cancer therapy: Hercules and hydra.
    Bellou S; Pentheroudakis G; Murphy C; Fotsis T
    Cancer Lett; 2013 Sep; 338(2):219-28. PubMed ID: 23707856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic therapy in pediatric brain tumors: an effective strategy?
    Sie M; den Dunnen WF; Hoving EW; de Bont ES
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):418-32. PubMed ID: 24169416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-angiogenic agents of lung cancer].
    Wakuda K; Takahashi T
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):162-71. PubMed ID: 24743195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
    Lyons JM; Anthony CT; Thomson JL; Woltering EA
    Ann Surg Oncol; 2008 Dec; 15(12):3407-14. PubMed ID: 18795370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of antiangiogenic therapies in the treatment of metastatic breast cancer.
    Ademuyiwa FO; Miller KD
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S151-6. PubMed ID: 19158035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic therapy in the management of breast cancer.
    Wu Y; Sun WL; Feng JF
    Asia Pac J Clin Oncol; 2013 Jun; 9(2):110-6. PubMed ID: 22898270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.